A light at the end of the dark tunnel of depression? A report published by the Centers ... The team noted, “These findings ...

Depression and anxiety rank among the top global health challenges. Since 1990, these disorders have surged, placing them in ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

A new trial suggests that at-home brain stimulation could potentially be a first-line treatment for depression. However, some experts are skeptical.

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

While Rejoyn is approved for depression, "it is not designed as a standalone treatment," says King ... The strategy likely won’t be as effective in psychiatric conditions where neurons in the brain ...

Computer-assisted cognitive-behavior therapy (CCBT) and mobile mental health applications warrant continued development and ...

The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression.

Prompt recognition and effective treatment of depression are of critical importance for improving the cancer patient's quality of life. Despite the efficacy of antidepressant medications ...

The cost of psilocybin-based treatment, priced at £1,200 ... is great potential for psilocybin to be a cost-effective therapy for severe depression – with higher quality impacts for the ...

Bright light therapy was associated with improved treatment response and remission rates among patients with nonseasonal depression.

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .